[Form 3] Organon & Co. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Organon & Co. (OGN) filed a Form 314,790.703 shares of common stock held directly.

It also lists restricted stock units (each RSU equals one share) covering common stock: 6,378 (exercisable 03/31/2025; final vesting 03/31/2026), 7,252 (11/07/2025; 11/07/2026), 15,958 (03/29/2026; 03/29/2027), and 30,221 (03/31/2026; 03/31/2028). The event date is 10/27/2025.

11/12/2025 - 05:47 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Drinane Juliana Papa

(Last) (First) (Middle)

C/O ORGANON &CO.

30 HUDSON STREET, FLOOR 33

(Street)

JERSEY CITY NJ 07302

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/27/2025

3. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim Head of Mfg & Supply

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,790.703	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	03/31/2025(1)	03/31/2026	Common Stock	6,378	(2)	D
Restricted Stock Units	11/07/2025(3)	11/07/2026	Common Stock	7,252	(2)	D
Restricted Stock Units	03/29/2026(4)	03/29/2027	Common Stock	15,958	(2)	D
Restricted Stock Units	03/31/2026(5)	03/31/2028	Common Stock	30,221	(2)	D

Explanation of Responses:

1. 19,132 restricted stock units ("RSUs") were granted on March 31, 2023, and one-third vest each year with the final vesting date being March 31, 2026.

2. Each RSU represents a contingent right to receive one share of common stock of Organon & Co.

3. 10,876 RSUs were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.

4. 23,936 RSUs were granted on March 29, 2024, and one-third vest each year with the final vesting date being March 29, 2027.

5. 30,221 RSUs were granted on March 31, 2025, and one-third vest each year with the final vesting date being March 31, 2028.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Organon (OGN) disclose in this Form 3?

An officer reported beneficial ownership of 14,790.703 shares of common stock (direct) and multiple RSU awards tied to Organon common stock.

How many Organon (OGN) common shares are directly owned?

The filing reports 14,790.703 shares of common stock held directly.

What RSU awards are included and when do they vest?

RSUs for 6,378 (final vesting 03/31/2026), 7,252 (11/07/2026), 15,958 (03/29/2027), and 30,221 (03/31/2028) are listed; each vests in one‑third annual installments.

What does each RSU represent for OGN?

Each RSU represents a contingent right to receive one share of Organon common stock.

What is the reporting person’s relationship to Organon (OGN)?

The reporting person is an Officer, titled Interim Head of Mfg & Supply.

What is the event date for this beneficial ownership report?

The event date is 10/27/2025.